biospecimen_aliquot__bcr_aliquot_barcode	tcga-ao-a0jj-01a-11w-a071-09
biospecimen_aliquot__bcr_aliquot_uuid	812191d1-6711-4efd-8932-c76159b60ffb
biospecimen_aliquot__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_aliquot__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0097500309
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-09-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	6
biospecimen_aliquot__plate_id	a071
biospecimen_aliquot__plate_row	b
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-ao-a0jj-01a-11w
biospecimen_analyte__bcr_analyte_uuid	ce5bd86c-fc31-494a-be86-d23bfde2c7e7
biospecimen_analyte__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_analyte__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ao-a0jj
biospecimen_diagnostic_slides__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	d5b636f5-1b47-4033-9938-9dc8cd48cee9
biospecimen_normal_control__bcr_patient_barcode	tcga-ao-a0jj
biospecimen_normal_control__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_normal_control__ncedna_dna_conc	155.47
biospecimen_normal_control__ncedna_dna_qm	nanodrop
biospecimen_normal_control__ncedna_dna_qty	46
biospecimen_normal_control__ncedna_dna_vol	300
biospecimen_portion__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_portion__bcr_portion_barcode	tcga-ao-a0jj-01a-11
biospecimen_portion__bcr_portion_uuid	1559e633-a600-49e1-9a16-4755ecf0cb57
biospecimen_portion__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_portion__date_of_creation	2010-06-22
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ao-a0jj-01a-11w
biospecimen_protocol__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_protocol__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_sample__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_sample__bcr_sample_uuid	008dafdd-a3d1-4801-8c0a-8714e2b58e48
biospecimen_sample__days_to_collection	1477
biospecimen_sample__initial_weight	260
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ao-a0jj.eb9b6625-6674-4665-9bee-d4dfd9366a02.pdf
biospecimen_sample__pathology_report_uuid	eb9b6625-6674-4665-9bee-d4dfd9366a02
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	c4fcf63c-a35e-451c-bf06-64b36bc30ba0
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13a
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ao-a0jj-01a-21-a13a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
biospecimen_slide__bcr_sample_barcode	tcga-ao-a0jj-01a
biospecimen_slide__bcr_slide_barcode	tcga-ao-a0jj-01a-01-bsa
biospecimen_slide__bcr_slide_uuid	132f03bb-3b31-485c-b814-0f4bf204440e
biospecimen_slide__image_file_name	tcga-ao-a0jj-01a-01-bsa.132f03bb-3b31-485c-b814-0f4bf204440e.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	20
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ao-a0jj
biospecimen_tumor_sample__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
clinical_drug__bcr_drug_barcode	tcga-ao-a0jj-d2968
clinical_drug__bcr_drug_uuid	099545fb-d2c8-42e3-8f4a-7757316b4d86
clinical_drug__bcr_patient_barcode	tcga-ao-a0jj
clinical_drug__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
clinical_drug__form_completion_date	2010-9-20
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	cyclophospamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/m2
clinical_drug__pharmaceutical_tx_ended_days_to	98
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	56
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	600
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	4800
clinical_follow_up__bcr_followup_barcode	tcga-ao-a0jj-f15493
clinical_follow_up__bcr_followup_uuid	0466f12c-73ba-4b3a-9794-698974812cf6
clinical_follow_up__bcr_patient_barcode	tcga-ao-a0jj
clinical_follow_up__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-8-22
clinical_follow_up__last_contact_days_to	1887
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	54
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant|left
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ao-a0jj
clinical_patient__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
clinical_patient__birth_days_to	-19758
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	4+
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-9-20
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_ihc_score	0
clinical_patient__her2_positivity_method_text	3+ positive
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2006
clinical_patient__last_contact_days_to	1512
clinical_patient__lymph_nodes_examined_count	44
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0jj
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	70-79%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ao
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ao-a0jj
clinical_radiation__bcr_patient_uuid	bef7b135-a727-45e8-850a-cc4cd56c49aa
clinical_radiation__bcr_radiation_barcode	tcga-ao-a0jj-r2967
clinical_radiation__bcr_radiation_uuid	dbd25158-9d0f-4bfc-aa40-b2b6ac9685ea
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-9-20
clinical_radiation__radiation_adjuvant_fractions_total	25
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	256
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	regional site
clinical_radiation__radiation_therapy_started_days_to	217
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	10000
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AO-A0JJ-01A-11W-A071-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AO-A0JJ-01A-11W-A071-09.bed.meta
manually_curated__id	tcga-ao-a0jj-01a-11w-a071-09
manually_curated__md5sum	285c8900be38982b5ad6544f61c80feb
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	812191d1-6711-4efd-8932-c76159b60ffb
manually_curated__tumor_tag	brca
